alt Hacker NewsExactly. The reality is that spitting out drug candidates is already the “easy” part… the harder part is getting that candidate through clinical trials, which is where 90% of such journeys end.
As always Anthropic is saying literally anything if it gets them closer to the giant bucket of money that is the IPO.
Replies
azan_ • today at 2:07 AM
So getting drug candidates with high success rate actually is the hard part.
If the candidates were better, then <90% would end their journeys at the clinical trials. Though that's not to say that they've provided any real evidence that their candidates actually are better yet